ProShare Advisors LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 53 filers reported holding TRANSLATE BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$851,000
+81.1%
30,907
+8.4%
0.00%
+100.0%
Q1 2021$470,000
-4.1%
28,500
+7.3%
0.00%
-50.0%
Q4 2020$490,000
+76.9%
26,568
+30.7%
0.00%
+100.0%
Q3 2020$277,000
-8.6%
20,320
+20.0%
0.00%
-50.0%
Q2 2020$303,000
+194.2%
16,930
+64.5%
0.00%
+100.0%
Q1 2020$103,000
-28.5%
10,290
-41.8%
0.00%0.0%
Q4 2019$144,000
-15.3%
17,675
+3.0%
0.00%0.0%
Q3 2019$170,000
-25.1%
17,153
-4.6%
0.00%0.0%
Q2 2019$227,000
+20.1%
17,980
-3.0%
0.00%0.0%
Q1 2019$189,000
+53.7%
18,544
+13.5%
0.00%0.0%
Q4 2018$123,00016,3350.00%
Other shareholders
TRANSLATE BIO INC shareholders Q1 2019
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,922,008$29,415,00015.52%
Omega Fund Management, LLC 2,437,603$18,282,00013.56%
DAFNA Capital Management LLC 228,939$1,717,0000.85%
Baupost Group 6,491,287$47,136,0000.41%
Rock Springs Capital Management LP 1,009,179$7,569,0000.36%
Bain Capital Public Equity Management, LLC 416,670$3,125,0000.29%
Cormorant Asset Management, LP 454,550$3,409,0000.28%
SPHERA FUNDS MANAGEMENT LTD. 309,400$2,321,0000.26%
Artal Group S.A. 600,000$4,500,0000.17%
Perceptive Advisors 435,000$3,167,0000.12%
View complete list of TRANSLATE BIO INC shareholders